Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - CASH & EQUIVALENTS
Cash & Equivalents KALV - KalVista Pharmaceuticals, Inc.
31.8 M
LAST VALUE
1.71%
2 YEAR CAGR
-0.14%
5 YEAR CAGR
12.51%
10 YEAR CAGR